Rebalix
Vanguard · sheet of 4 September 2026
Vanguard · sheet of 4 September 2026ETF sheet · official issuer and register data
Vanguard FTSE All-World UCITS ETF (USD) Accumulating
VWCE · IE00BK5BQT80 · USD · domicile Ireland
Equity · GlobalSFDR art. 6 (inferred)
Index tracked: FTSE All World Index
- TER
- 0.14%+ trans. 0.03%
- Fund size
- 69.1 bn EUR
- Tracking difference
- −0.01%3-year avg
- 🇮🇹 tax rate
- 26.00%equity
- Replication
- Physical (sampled)
- Income
- Accumulating
Launch 23 Jul 2019 · costs from the KID as of 2 Sept 2026 · 4,285 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE All-World Index (the “Index”). The Index is comprised of large and mid-sized company stocks in developed and emerging markets. The Fund attempts to: 1. Track the performance of the Index by investing through physical acquisition in a representative sample of Index constituent securities. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund…
Performance since series start (in euro) — base 100
31 Aug 2019 → 31 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +26.2% |
| 3 years | +58.8% |
| 5 years | +74.2% |
| 10 years | series too young |
| Since series start | +134.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.25% | 11.85% | 13.50% |
| Max drawdown | −9.29% | −15.70% | −26.22% |
| Sharpe | 1.62 | 1.30 | 0.62 |
| Sortino | 2.42 | 1.88 | 0.88 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VWCE · IE00BK5BQT801
RebalixVWCE · IE00BK5BQT80 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +22.56% | +22.62% | −0.06% |
| 2024 | +17.19% | +17.20% | −0.01% |
| 2023 | +22.03% | +22.00% | +0.03% |
| 2022 | −18.08% | −18.07% | −0.01% |
| 2021 | +18.33% | +18.40% | −0.07% |
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 4,285 securities · top-10 weight = 23.5%
| Top holdings | Weight |
|---|---|
| 4.4% | |
| 4.2% | |
| 3.3% | |
| 2.5% | |
| 2.0% | |
| 1.7% | |
| 1.7% | |
| 1.6% | |
| 1.2% | |
| 0.9% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VWCE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 22 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BK5BQT80
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BK5BQT80
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VWCE · IE00BK5BQT802